Skip to main content


Showing posts from May 19, 2013

New treatments see blood cancer survival rates up

New treatments see blood cancer survival rates up - Scotsman
— Cancer Survivors (@Cancer_Buzz) May 22, 2013
The formula above is not meant as a math trick.  But it does depict some tricky math for cancer survivors like me.

All that I have to say about this search and this topic is that it is good to be counted among the one in four.  That is, according to this source, one in four NHL (non-Hodgkin's lymphoma) survivors have a chance of surviving for five years.   Count me at 5.8 years since my stem cell transplant and 7 years since the diagnosis of mantle cell lymphoma (MCL), a potent form of NHL.

Reading this article and seeing this illustration of the three bags of stem cells makes for a personal flashback to the August 2007 SCT procedure at City of Hope.

MYJ ZONE (My Journal)
Social Current See }:{ Mike Foxworth
ASK ME HOW TO NEVER FORGET A PASSWORD AGAIN publisher for constant web and mobile communication ___ http://altacities.comThe alterna…

When the diagnosis is certain, but the path is unclear

MYELOFIBROSIS : Just learned in the last few days that a close friend has been diagnosed with myelofibrosis, a serious bone marrow disorder that disrupts the body's normal production of blood cells. The result is extensive scarring in bone marrow, leading to severe anemia, weakness, fatigue, and often, an enlarged spleen and liver.  The news was shocking to hear and a flashback to the time seven years ago when I was diagnosed with MCL (mantle cell lymphoma).

Given that fact that I did not know about myelofibrosis, nor that the disease is a type of chronic leukemia — a cancer that affects the blood-forming tissues in the body, I am on a web search for facts. Myelofibrosis can occur on its own (primary myelofibrosis) or it can occur as a result of another bone marrow disorder (secondary myelofibrosis), according to the Mayo Clinic.

An 'orphan disease' is one that has not been adopted by the pharmaceutical industry because it provides little financial incentive for the priva…

Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer

Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer }:{ My August 2007 stem cell transplant (SCT) was done with adult cells from an unrelated donor.  While the procedure is fraught with risks, mortality, and morbidity factors for the recipient, an SCT or the BMT (bone marrow) equivalent is virtually harmless to the adult donor.   Scientists have finally cloned human embryonic stem cells
— Forbes Tech News (@ForbesTech) May 22, 2013}:{  alt@search  }:{  alt@story}:{ 
Because I was the recipient of life-saving stem cells 5.8 years ago, I am naturally more than a casual observer of the science.  But everyone who seriously follows this story line and these tweets, realizes that society and medicine at large both face certain ethical questions regarding transplants using embryonic cells.  While the adult cells issue is largely resolved, I am not sure that this "breakthrough" cloning of embryonic cells solves the larger ethical issue, but it does bri…